BON Unveils Discovery of Potential Weight-Management Compounds from Tea Using AI-Driven Drug Development Platform

Written by Emily J. Thompson, Senior Investment Analyst

Source: Newsfilter

Updated: Sep 02 2025

0mins

BON0%

Should l Buy BON?

Source: Newsfilter

Breakthrough in Weight Management: Bon Natural Life Limited has identified a new class of natural polyphenolic compounds from tea that show significant potential for weight management, outperforming existing drugs in preliminary tests, thanks to its AI-powered R&D platform.
Market Growth Potential: The global weight-managing product market is projected to grow from USD 423.27 billion in 2024 to USD 601.26 billion by 2029, driven by rising obesity rates and increased awareness of healthy weight management, positioning BON to capture a significant market share with its new drug development.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy BON?" and start using high-conviction signals backed by rigorous historical data.

BON

$1.63+Infinity%1D

Analyst Views on BON

About BON

Bon Natural Life Ltd is a China-based company principally engaged in the manufacturing and sales of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements, such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. The Company's product categories include fragrance compounds, health supplements (natural, functional active ingredients for powder drinks) and bioactive food ingredients. Fragrance compounds product category includes clary sage extract products. Bioactive food ingredients include stachyose, milk thistle extracts, apple extracts, phloretin and pomegranate extract products. The Company’s products are applied in the functional food, personal care, cosmetic and pharmaceutical industries.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

BON Partners with Qingshengyuan in $12M Health Product Agreement

Dec 10 2025PRnewswire

Strategic Partnership: BON has entered into a 24-month non-exclusive sales agreement with Qingshengyuan valued at $12 million, aimed at leveraging Qingshengyuan's distribution network in Greater China to promote BON's high-tea-pigment products, significantly enhancing market penetration.
Product Innovation: BON has launched a health-focused kombucha-inspired beverage made from premium tea, sugar, and a Symbiotic Culture of Bacteria and Yeast (SCOBY), which undergoes a controlled natural fermentation process that ensures higher tea pigment concentration than similar products, catering to consumer demand for natural ingredients.
Market Trend Alignment: With increasing interest among younger consumers in natural ingredients and health benefits, kombucha has emerged as one of the fastest-growing categories in functional beverages, and BON's product is designed to capitalize on this trend, supporting further market development.
Broad Industry Outlook: The market for tea-pigment applications is projected to reach approximately $1 billion in the coming years, and BON's strategic collaboration is expected to enhance its influence in the functional product industry, driving future revenue and earnings growth.

BON Partners with Qingshengyuan for $12M Strategic Collaboration

Dec 10 2025Newsfilter

New Product Launch: BON has introduced a health-focused kombucha-inspired beverage made from premium tea and SCOBY through natural fermentation, aiming to meet consumer demand for more efficient, pure, and scientifically formulated tea-based products, which is expected to drive market growth.
Strategic Sales Agreement: BON has signed a 24-month non-exclusive sales agreement valued at $12 million with Qingshengyuan, which will distribute BON's high-tea-pigment products across Greater China, enhancing market penetration.
Market Potential: The tea-pigment market is projected to reach approximately $1 billion in the coming years, and BON's product is positioned to capitalize on this trend, further expanding its market share in the functional beverage sector, particularly among younger consumers.
Brand Impact Enhancement: BON's CEO stated that this collaboration will leverage both parties' resources to increase brand awareness and promote broader acceptance of health-focused concepts, thereby strengthening BON's competitiveness and long-term shareholder value in both domestic and international markets.

Bonchon Launches Limited-Time Korean Comfort Menu to Satisfy Winter Cravings

Dec 09 2025Globenewswire

Winter Menu Launch: Bonchon introduces a limited-time Korean comfort menu featuring classic dishes like dumpling soup, Korean-style omelet fried rice, and sausage-and-rice-cake skewers, aimed at satisfying customers' cravings for warmth and comfort during the cold season.
Cultural Sentiment Fusion: The new menu conveys the cultural sentiment of Korean comfort food through simple ingredients and rich flavors, designed to provide customers with a nostalgic dining experience that strengthens the emotional connection between the brand and its patrons.
Diverse Service Options: The new dishes are available for dine-in, pick-up, and delivery, allowing customers to enjoy warm Korean cuisine at home, which enhances the brand's market competitiveness by offering flexible dining solutions.
Brand Expansion and Recognition: Bonchon operates over 150 restaurants in the U.S. and nearly 500 worldwide, renowned for its unique double-fried chicken, and was recently recognized by Fast Casual Magazine as a top brand for 2025, reflecting its growing market influence.

BON Partners with Huahai Keyuan for $26 Million Digestive Health Product Agreement

Nov 25 2025Newsfilter

Cooperation Agreement Signed: BON has entered into a 36-month non-exclusive cooperation agreement with Huahai Keyuan, valued at $26 million, aimed at promoting the sales and distribution of its second-generation tea pigment-based digestive health products in Greater China.
Significant Market Potential: As a next-generation functional tea ingredient, tea pigments are projected to exceed a $1 billion market opportunity, primarily driven by the rapidly growing segments of digestive wellness and blood-glucose management, indicating strong consumer demand trends.
Enhanced Product Efficacy: BON's optimized fermentation process has resulted in over a 200% increase in the digestive health activity of its second-generation tea pigment product, significantly enhancing product efficacy and strengthening the company's competitive positioning in the market.
Strategic Development Phase: CEO Hu Yongwei stated that this partnership will accelerate BON's expansion into the premium digestive health market, with expectations of meaningful revenue and earnings growth, further enhancing long-term shareholder value.

BON Announced Next-Gen of Tea Pigment Digestive Health Products and Cooperation Agreement of US$26 Million with Beijing Huahai Keyuan

Nov 25 2025PRnewswire

Cooperation Agreement: Bon Natural Life Limited has entered a 36-month non-exclusive cooperation agreement with Beijing Huahai Keyuan Technology Co. Ltd. to distribute its second-generation tea pigment-based digestive health products in Greater China, valued at US$26 million.
Innovative Product Development: BON has enhanced the digestive health benefits of its tea pigments by over 200% through a controlled biotransformation process, positioning the product as a significant advancement in the market.
Market Potential: The tea pigments are expected to tap into a market opportunity exceeding US$1 billion, driven by growing consumer demand in digestive wellness and blood-glucose management.
Strategic Growth Plans: CEO Hu Yongwei emphasized that this partnership will accelerate BON's expansion into the premium digestive health market and support long-term revenue and earnings growth.